AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product ...

Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer ...

Alert: Claims Focus on Alleged Misrepresentations About Clinical Trial Integrity and Drug SafetyNEW YORK--(BUSINESS ...

GoldCoast Closes First Tranche of Private Placement TORONTO, ON / ACCESS Newswire / March 17, 2026 / Psyence Group Inc.

Dr. Chen expands his leadership role to serve as President while continuing to serve as Chief Medical Officer (CMO), unifying R&D innovation with operational execution as Personalis defines the next ...

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader antibody ...

New platform aims to better characterize tumor cell populations that survive therapy and drive cancer ...

Preclinical data demonstrate how Soley’s proprietary drug discovery platform translates cell stress biology into first-in-class drug candidatesSOUTH SAN FRANCISCO, Calif.--(BUSINESS ...

DORADO, PUERTO RICO / ACCESS Newswire / March 17, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") ...

Record Revenue and IRRAS Holdings Acquisition Highlight the Company's 'Fast. Forward.' Strategy SOLANA BEACH, CA / ACCESS ...

HOHCells launches FreezOpt™, a new cryopreservation consumable device designed to improve consistency in biological research ...

Surf Therapeutics, a clinical-stage company developing non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases, today reported positive first-in-human study results and ...